
JCLI provides a multidisciplinary platform for original research, randomized clinical trials, registry studies, and expert reviews related to the diagnosis, treatment, and prevention of limb-threatening vascular diseases.
Leadership transition brings expanded expertise and global vision to the only peer-reviewed journal focused exclusively on CLTI and severe PAD
The Journal fills a critical gap in the scientific literature by focusing exclusively on CLTI and severe PAD. I am committed to maintaining its scientific rigor and expanding its global readership.”— Jos C. van den Berg, MD, PhD
MALVERN, PA, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Jos C. van den Berg, MD, PhD has been named Editor-in-Chief of the Journal of Critical Limb Ischemia, the only peer-reviewed publication dedicated to chronic limb-threatening ischemia (CLTI) and peripheral artery disease (PAD). Published by the Critical Limb Ischemia Global Society and HMP Global, the journal supports global multidisciplinary efforts to prevent amputations and improve vascular outcomes.
What is the Journal of Critical Limb Ischemia?
The Journal of Critical Limb Ischemia (JCLI) is a quarterly, peer-reviewed academic journal